Pasithea Therapeutics (KTTA) Stock Highlights

2.63 | -1.5%

2024-12-21 07:45:45

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.

Statistics

Range Today

2.58 2.81

Volume Today 22.8K

Range 1 Year

2.37 9.4

Volume 1 Year 62.69M

Range 3 Year

2.37 47.6

Volume 3 Year 80.86M

Range 10 Year

2.37 170

Volume 10 Year 95.94M

Highlights

Market Capitalization 3.33M (micro)

Floating Shares 802.65K

Current Price 2.63

Price To Earnings -0.17

Price To Book 0.12

Earnings Per Share -15.31

Payout Ratio 0%

Performance

Latest -1.5%

1 Month -21.96%

3 Months -43.8%

6 Months -48.53%

1 Year -51.3%

3 Years -91.11%

5 Years -96.71%

10 Years -96.71%

Benchmarks

Market Capitalization

350 / 368

Gross Profits

0 / 278

Total Revenue

251 / 300

Total Rank

224 / 368

Free Cashflow

92 / 352

Performance 5 years

334 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.